Somatostatin receptor scintigraphy in MALT lymphoma of the lacrimal gland treated with rituximab

Daniel Morgensztern, Manuel F. Rosado, Aldo N. Serafini, Izidore S. Lossos

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Non-gastric stage I extranodal marginal zone lymphomas of MALT are usually treated with local therapy. However, distant relapses in other extranodal sites are not uncommon suggesting under-staging of these patients using conventional image studies. Positron emission tomography (PET) scans are frequently negative in this subgroup of patients with lymphoma and therefore do not significantly contribute to the staging process. We present a case of lacrimal gland MALT lymphoma demonstrating the usefulness of somatostatin receptor scintigraphy for initial staging and evaluation of response to treatment.

Original languageEnglish
Pages (from-to)1275-1278
Number of pages4
JournalLeukemia and Lymphoma
Volume45
Issue number6
DOIs
StatePublished - Jun 1 2004
Externally publishedYes

Keywords

  • Lacrimal gland
  • MALT lymphoma
  • Somatostatin receptor scintigraphy

Fingerprint Dive into the research topics of 'Somatostatin receptor scintigraphy in MALT lymphoma of the lacrimal gland treated with rituximab'. Together they form a unique fingerprint.

Cite this